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AbstrACt
Objective Healthy eating and physical activity may help 
endometrial cancer survivors (ECS) improve their quality 
of life. However, most ECS do not meet the relevant 
guidelines. This pilot trial aimed to test the study feasibility 
procedures for a definitive trial of a behavioural lifestyle 
programme.
Design and setting This 24-week parallel two-arm 
randomised pilot trial took place in two hospitals in 
London, UK (April 2015–June 2016).
Participants Sixty disease-free ECS within 3 years of 
diagnosis.
Interventions Participants were randomised using 
minimisation to receive the intervention or care as usual. 
The ‘Shape-Up following cancer treatment’ programme 
used self-monitoring, goal-setting, self-incentives, 
problem-solving and group social support for 12 hours 
over 8 weeks to help survivors improve their eating and 
physical activity.
Outcome measures The main outcome measures were 
recruitment, adherence, and retention rates. Further 
outcomes included barriers to participation and feedback 
on programme satisfaction.
results Of the 296 potentially eligible ECS, 20% (n=60) 
were randomly allocated to the active intervention (n=29) 
or control group (n=31). Three participants in each arm 
were deemed ineligible after randomisation and excluded 
from analysis. Twenty participants (77%; 95% CI 61% to 
93%) adhered to the intervention and provided generally 
favourable feedback. At 24 weeks, 25/26 (96%; 95% CI 
89% to 100%) intervention and 24/28 (86%; 95% CI 73% 
to 99%) control participants completed their assessment. 
No intervention-related adverse events were reported. 
Among eligible survivors who declined study participation 
(n=83), inconvenience (78%; 95% CI 69% to 87%) was the 
most common barrier.
Conclusions The trial was feasible to deliver based on 
the a priori feasibility criteria. Enhancing recruitment and 
adherence in a definitive trial will require designs that 
promote convenience and consider ECS-reported barriers.
trial registration number NCT02433080; Pre-results.
trial funding University College London, St. 
Bartholomew’s Hospital Nurses League, and NIHR 
University College London Hospitals Biomedical Research 
Centre.
IntrODuCtIOn
Endometrial cancer is the most common 
gynaecological cancer with about 455 000 
incident cases worldwide in 2015. It affects 
mostly women in developed countries1 and 
about 75% women will live for more than 10 
years after diagnosis.2 They are the cancer 
group with the highest comorbidity burden 
among survivors3 and are most likely to die 
from cardiovascular disease.4 Furthermore, 
the prevalence of obesity and suboptimal 
lifestyle behaviours is high, both of which are 
associated with lower health-related quality of 
life.5 Although most survivors do not sponta-
neously adopt health-protective behaviours6 
postdiagnosis, they do report trying to make 
strengths and limitations of this study
 ► This trial tested the feasibility of a standardised 
theory-based behavioural lifestyle programme 
for endometrial cancer survivors using a robust 
randomised parallel design.
 ► Barriers to participation were systematically 
assessed.
 ► The study aimed to minimise these barriers by 
recruiting survivors within the ‘teachable moment’ 
period and capitalising on the endorsement of the 
study from their clinicians.
 ► The small sample size and recruitment from 
London-based hospitals limit the generalisability of 
the outcomes.
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lifestyle changes. However, they experience cancer-spe-
cific barriers, such as fatigue and bowel issues, and feel 
there is a lack of guidance.7
Behavioural lifestyle interventions improve patient-re-
ported outcomes, such as health-related quality of life, in 
other cancer survivor groups.8–10 Randomised controlled 
trials (RCTs) in endometrial cancer survivors (ECS) have 
also shown that health behaviour change is feasible for 
these patients.11 12 However, the programmes tested to 
date have been resource-intensive rendering their wide-
spread dissemination challenging. There is, therefore, a 
need for effective lifestyle behaviour change interventions 
that can be adopted within the cancer care pathway. We 
have adapted an existing evidence-based lifestyle inter-
vention,13 which is already running within the healthcare 
system, to try and facilitate this process.14 The interven-
tion was adapted to the particular needs and preferences 
of ECS, with patient input and using the intervention 
mapping approach. A definitive RCT will indicate 
whether this intervention is effective in promoting long-
term behaviour change and improving survivors’ quality 
of life. This pilot study was conducted to test the feasibility 
of the planned RCT’s procedures.
The primary objective of the pilot trial was therefore 
to calculate recruitment, adherence, and retention rates. 
Secondary outcomes included willingness of clinical staff 
to recruit participants, potential adverse events, barriers 
to participation, reasons for attrition, and participants’ 
study experience.15
MethODs
study design and participants
The trial protocol has been published.15 The DEUS 
(Diet and Exercise in Uterine Cancer Survivors) pilot 
trial was an 8-week, two-arm, parallel, controlled pilot 
trial with 1:1 randomisation comparing the use of the 
‘Shape-Up following cancer treatment’ programme to 
care as usual.
Women aged ≥18 years who had been diagnosed with 
endometrial cancer (ICD C54.1) within the previous 36 
months were eligible to take part in the study. Women 
were excluded if (1) they were diagnosed with stage IVB 
cancer; (2) they were on active anticancer and/or pallia-
tive treatment; (3) they had a second primary cancer; (4) 
they lacked mental capacity to decide to take part in the 
study and to participate in it; (5) they had severe depres-
sion; (6) they were unavailable for longitudinal follow-up 
assessments; (7) they had participated in a profession-
ally delivered weight loss or exercise programme during 
the previous 6 months; (8) their performance score was 
3–416 (9) or they were unable to understand spoken and 
written English.
At the fifth week of recruitment, the inclusion criterion 
‘women willing to attend all sessions’ was removed given 
the subjective nature of its interpretation and the exclu-
sion criterion ‘women with secondary cancer’ was added 
to ensure homogeneity.
recruitment
Potential participants were recruited from the gynae-
cology outpatient clinics at University College London 
Hospitals (UCLH) and Barts Health. Interested and 
potentially eligible participants were introduced to the 
study by clinicians and researchers attending the clinics 
as previously described.15
The clinicians at UCLH also identified potential partici-
pants that had been treated there but followed up at local 
sites. Following general practitioner’s verification that 
the patients were alive, invitation letters signed by the 
consultant were sent to these women together with the 
participant information sheet, an opt-in form, a barriers 
to participation survey and a business reply envelope.
randomisation and blinding
Consented participants were randomised with a 1:1 allo-
cation to receive either the intervention or usual care 
through minimisation using age and body mass index 
(BMI) as stratified variables. The process has been previ-
ously described in detail.15 The researcher assessing the 
8-week outcomes (MM) was blinded to intervention allo-
cation and participants were requested prior to the assess-
ment not to disclose their allocation.
shape-up following cancer treatment intervention
In addition to usual care, intervention-arm participants 
received the ‘Shape-Up following cancer treatment’ 
manual and were assigned to groups of three to eight, 
although the initial plan was that they would be assigned 
in groups of eight. The allocation to groups was on a first-
come, first-served basis to avoid delays in delivering the 
intervention to randomised participants and aimed to 
match participant preferences for dates and times of the 
group meetings. The five groups met weekly for 8 weeks 
at UCLH. Each session lasted approximately 90 min. 
The theory-based intervention has been previously 
described.15 In brief, it included advice on healthy eating, 
physical activity, management of triggers of unhealthy 
behaviours and behavioural relapse prevention. A dieti-
tian (DAK) trained on the programme facilitated the 
group sessions following a standardised and scripted 
protocol. An extra trained provider (psychologist or dieti-
tian) attended the meetings of the four groups to aid with 
facilitation but did not participate in the discussion. DAK 
was the only facilitator in the last group because of last 
minute cancellations. The participants in the fourth and 
final round of randomisation were split into two small 
intervention groups for convenience purposes. A partic-
ipant from the control group who had completed the 
study was invited to participate in the last group (final 
n=4 in group 5) to enhance the group experience but 
was not included in the analysis. There were no other 
modifications. The completed Consolidated Standards of 
Reporting Trials (CONSORT)17 and Template for Inter-
vention Description and Replication (TIDieR) check-
lists18 are available in online supplementary appendices 
S1 and S2, respectively.
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Care as usual
Participants in the control arm were offered usual care. 
After the final follow-up, they received a booklet with 
healthy lifestyle advice for cancer survivors.19
OutCOMes
Recruitment rates were calculated separately for each 
strategy and site. We adapted an existing framework 
of hierarchical recruitment barriers (availability by 
disease characteristics, eligibility, physician triage, 
trial discussion, interest, consent, and enrolment)20 to 
describe the recruitment process. In contrast with the 
original framework, the category ‘interest’ preceded 
that of ‘trial discussed’ to fit the current recruit-
ment process. Participants who were introduced 
to the study and decided not to enrol completed a 
25-item investigator-designed survey21 about barriers 
to participation. Eight UCLH clinicians were inter-
viewed about their views on study recruitment using 
a semistructured protocol over phone or face-to-face 
(online supplementary appendix S3).
Participants attended a 90-min baseline site visit 
with a trained researcher (DAK) to complete their 
measurements and questionnaires. The visit was 
repeated at 8 and 24 weeks with MM and DAK, respec-
tively. All intervention sessions were audiotaped. RJB 
attended one intervention session and one study assess-
ment and scored them against a predefined checklist. 
Engaged intervention-arm participants completed 
and posted an 18-item programme evaluation ques-
tionnaire.22 Only two follow-up qualitative interviews 
with intervention participants were performed at 
study completion, as the data from the open-ended 
feedback questionnaire were deemed sufficient.
statistical and qualitative analysis
Despite the pilot nature of the study, a sample size of 
32 participants per arm was estimated for examining 
recruitment, adherence, and retention rates. The 
study would be deemed feasible if the lower 95% CIs 
for recruitment, adherence and retention rates were 
at least 15%, 60%, and 60%, respectively.15
Primary outcomes are reported in proportions with 
95% CIs. Descriptive statistics are reported for contin-
uous variables. Categorical variables are summarised 
using frequencies and percentages. The interviews 
with clinicians lasted 10 min on average, were digi-
tally recorded, transcribed verbatim by a professional 
company and checked for accuracy. Given the struc-
tured interview and short replies, data were analysed 
with content analysis using NVivo V.10 (QSR Inter-
national, 2014) software. The open-ended questions 
were analysed using manifest content analysis23 in 
Microsoft Office Excel V.2011. This process involved 




Recruitment took place over a period of 27 and 18 weeks 
(April 2015–December 2015) at UCLH and Barts Health, 
respectively (figure S1 of online supplementary appendix 
S3). The difference in recruitment period between sites 
was primarily explained by substantial delay of NHS 
Research and Development management approval at 
Barts Health. Among the first 64 eligible participants 
approached, 20 consented to participate, leading to 
rejection of the null hypothesis that recruitment would 
be ≤15%. Therefore, recruitment continued for enrolling 
the projected sample of 64 participants but stopped after 
enrolling 60 participants due to resource constraints. Out 
of 296 potentially eligible participants, 20.3% (95% CI 
15.7% to 24.9%) enrolled in the study. Among screened 
participants, rates of consent were similar for the face-to-
face recruitment at the two recruitment sites but lower for 
the mail-out (tables S1 and S2 of online supplementary 
appendix S3).
Reasons for non-participation were documented for 
36.7% (n=83) of those who were potentially eligible but 
did not consent and 90.2% of those that were approached. 
Inconvenience to everyday life (78%) and transport to 
trial site (63%) were the main barriers to participation, 
with further barriers detailed in table 1 and less frequent 
barriers in table S3 of online supplementary appendix 3. 
The CONSORT flow diagram shows the progress through 
the trial stages (figure 1).
Clinicians’ views on recruitment
Clinicians were supportive of the study and did not 
have particular concerns about introducing the study 
to patients. They felt the study might be beneficial to 
patients, but they believed travelling and commitment 
would be the main barriers for recruitment.
They deemed the recruitment strategy highly effective, 
with potentially eligible patients being flagged prior to 
the clinic, researchers being present and reminding them 
about approaching patients, and through the existence of 
a separate space for study recruitment in the clinic. These 
strategies minimised additional clinician workload.
Clinicians did not anticipate adverse events from the 
intervention or changes in their relationship with the 
patients. The framing and content of such an intervention 
was also highlighted as a potential barrier to recruitment. 
In particular, approaching patients in a non-discrimina-
tory way was deemed to enhance recruitment. Further-
more, framing of its content as a lifestyle programme was 
thought to be superior to a weight loss programme, strict 
diet regime or educational programme.
sample characteristics
Participant characteristics at baseline are shown in table 2. 
Women were on average (±SD) 62.1±8.3 years old, white 
(67%), married (53%), 1.2±1.0 years from diagnosis, with 
a BMI of 28.0±6.3 kg/m2. They were diagnosed mostly 
with stage IA (49%), type 1 (82%) endometrial cancer.
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Adherence
Out of 26 participants in the intervention arm, 21 (81%; 
95% CI 66% to 96%) engaged and 20 (77%; 95% CI 
61% to 93%) adhered to the intervention, based on our 
predetermined criteria.15 The lower CI was above 60% 
indicating feasibility.
The percentage of participants who attended zero, 
five, six, seven, and eight (all) sessions was 15%, 8%, 
12%, 35%, and 15%, respectively. The mean overall 
attendance of sessions was 63% (95% CI 49% to 77%). 
The mean attendance rates of those who engaged and 
those who adhered were 79% (95% CI 70% to 88%) and 
82% (95% CI 74% to 89%), respectively. Reasons for not 
commencing the intervention (ie, attendance of zero 
sessions) included inconvenience to everyday life (n=1), 
family commitments (n=1), lack of perceived benefit 
(n=1) or travel burden (n=1). The remaining two drop-
outs occurred in the first two sessions due to programme 
content and travelling abroad. Absence from the group 
sessions among adhered participants were mostly of prac-
tical nature, with details available in online supplemen-
tary appendix S3.
Programme satisfaction
Eighteen participants randomised to the interven-
tion group who adhered provided feedback for the 
programme. They scored the programme highly with 
44% and 39% reporting that it met or exceeded their 
expectations, respectively. All aspects of the programme 
were scored highly (table 3). Additionally, most partici-
pants ranked self-monitoring, setting specific, measur-
able, achievable, relevant, and time-specific goals, and 
social support as either very or somewhat helpful in 
making dietary and physical activity changes (table 4). In 
contrast, the responses for self-incentives were mixed with 
28% of participants rating this technique as unhelpful.
A range of topics were regarded as most useful (figure 
S2 of online supplementary appendix S3). Among them, 
most participants agreed that the sections about keeping 
an eye on portion sizes, food labelling and internal trig-
gers were the most useful. Others mentioned self-incen-
tives, internal and external triggers and getting a healthier 
balance of foods to be the least useful topics (figure S3 
of online supplementary appendix 3). For example, one 
participant mentioned:
I also did not understand the concept of the rewards—
better health should be its own reward (Participant in 
group 4).
Suggestions for additions to the programme were 
primarily focused on physical activity, such as provision 
of relevant digital video discs, physical activity during the 
programme sessions and diaries to report physical activity 
and sedentary behaviour in more detail. Most participants 
did not consider that topics should be eliminated from 
the programme. Similar feedback was provided for the 
booklet; most participants did not suggest changes while 
a few suggested design changes. Further suggestions 
included the addition of follow-up support and a pref-
erence for a larger group (mentioned by participants in 
smaller groups) to boost the peer-education component.
Peer support of the group, both the focus of the 
programme and their own interest in health promo-
tion, the feeling of giving back to the care system, the 
facilitators and the doctor’s referral to the programme 
facilitated study participation. In contrast, most did not 
report factors discouraging them to participate, but some 
mentioned inconvenience to everyday life, self-moni-
toring, and identification as a cancer survivor.
Regarding the trial procedures, two participants 
mentioned their difficulty recalling and quantifying their 
diet and physical activity. Excellent fidelity to the protocol 
for both the group sessions (85%) and the assessments 
(100%) was demonstrated in the study auditing.
retention
Retention rate was 92% (95% CI 85% to 100%), with 
24/28 (86%; 95% CI 73% to 99%) and 25/26 (96%; 
95% CI 89% to 100%) eligible participants in the control 
and intervention arm completing all assessments, respec-
tively (p=0.61 for difference between proportions). This 
Table 1 Percentage of each barrier to participation with SE 
among eligible survivors who declined participation (n=83)
Barrier to participation % (SE)
Inconvenient to everyday life 78.3 (4.5)
Transport or distance to trial site 62.7 (5.3)
Feelings of uncertainty 15.7 (4.0)
Lack of family support 15.7 (4.0)
The design of the study is too difficult to 
understand or too binding
15.7 (4.0)
Trial or treatment has no benefits 15.7 (4.0)
Other: feeling physically unwell 14.5 (3.9)
Preference for other treatment (eg, Weight 
Watchers) 13.3 (3.7)
Increased anxiety 12.1 (3.6)
Quality of life might be reduced 12.1 (3.6)
Trial or treatment does not offer best option 12.1 (3.6)
Trial setting 9.6 (3.2)
Uncomfortable with experimentation 9.6 (3.2)
Do not want to lose control of decision-
making 7.2 (2.8)
General unease with research process 7.2 (2.8)
Other: does not like to discuss in groups 6.0 (2.6)
Belief that doctor should make decisions 4.8 (2.4)
Dislike idea of randomisation 4.8 (2.4)
Fear or mistrust of research or researchers 4.8 (2.4)
Other: family health issues 4.8 (2.4)
Assignment to control group 3.6 (2.1)
Potential side effects 3.6 (2.1)
Trials not appropriate for serious disease 2.4 (1.7)
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Figure 1 Consolidated Standards of Reporting Trials diagram of the trial with framework on barriers to participation in the 
exclusion box. wk, week.
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Table 2 DEUS pilot trial baseline participant characteristics
Characteristic Shape-Up (n=25) Care as usual (n=24) Total
Age, mean (SD) 62.6 (9.0) 61.5 (7.7) 62.1 (8.3)
Race
  White 17 (68) 16 (67) 33 (67)
  Asian 4 (16) 5 (21) 9 (18)
  Other 4 (16) 3 (12) 7 (14)
Living arrangement
  Own outright/mortgage 17 (68) 15 (63) 32 (65)
  Rent 8 (30) 9 (38) 17 (35)
Marital status
  Married/living with partner/civil partnership 12 (48) 15 (63) 27 (55)
  Separated/divorced 7 (28) 3 (12) 10 (20)
  Widowed/single 6 (24) 6 (25) 12 (24)
Education
  Degree/higher degree/higher education below 
degree level
11 (44) 12 (50) 23 (47)
  Secondary education 11 (44) 10 (42) 21 (42)
  No formal qualifications 3 (12) 2 (8) 5 (10)
Employment
  Full time/self-employed 9 (36) 11 (46) 20 (41)
  Part time/other 6 (24) 2 (8) 8 (16)
  Retired 10 (40) 11 (46) 21 (43)
Smoking
  Current 2 (8) 2 (8) 4 (8)
  Former 4 (16) 5 (21) 9 (18)
IMD (quintile)
  1 (most deprived) 5 (20) 4 (17) 9 (18)
  2 9 (36) 6 (25) 15 (31)
  3 4 (16) 7 (29) 11 (22)
  4 3 (12) 3 (13) 6 (12)
  5 (least deprived) 4 (16) 4 (17) 8 (16)
Time since diagnosis in months, mean (SD) 19.2 (11.2) 21.4 (11.3) 20.3 (11.2)
Time since completion of primary treatment in 
months, mean (SD)
17.1 (11.2) 18.5 (11.7) 17.8 (11.3)
Surgery 25 (100) 24 (100) 49 (100)
Chemotherapy treatment 3 (12) 5 (21) 8 (16)
External beam radiotherapy 6 (24) 12 (50) 18 (37)
Brachytherapy 11 (44) 13 (54) 24 (49)
Cancer stage
  IA 11 (44) 13 (54) 24 (49)
  IB 11 (44) 6 (25) 17 (35)
  II 2 (8) 3 (13) 5 (10)
  IIIA 1 (4) 2 (8) 3 (6)
Cancer grade
  1 6 (24) 7 (29) 13 (27)
  2 13 (52) 9 (38) 22 (45)
Continued
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indicated an absence of attrition bias and the rejection of 
the null hypothesis that retention rate would be less than 
60%.
Adverse events and control arm contamination
No intervention-related adverse events or unintended 
consequences were reported. Adverse events unrelated to 
the intervention and reasons for control arm contamina-
tion are detailed in the online supplementary appendix 
S3.
DIsCussIOn
This is the first pilot study of a health behaviour change 
intervention in ECS in the UK to demonstrate feasibility 
in terms of recruitment, adherence, and retention. The 
collaboration of the clinical and research team led to 
an efficient recruitment process. Participants rated the 
programme highly and provided rich feedback for refine-
ment. Consistent with the literature24 and the qualita-
tive findings,7 the DEUS pilot study aimed to minimise 
accrual barriers by enrolling survivors within the ‘teach-
able moment’ period, capitalising on the endorsement 
of the study from survivors’ clinicians, using a strong 
behaviour theory-based design and ensuring standardised 
delivery of the intervention. These study strengths were 
also reflected in the reported factors associated with 
programme involvement. Furthermore, the frameworks 
for reporting barriers to participation20 21 provided a 
comprehensive understanding of these barriers and can 
be a valuable resource to understand barriers in for future 
Characteristic Shape-Up (n=25) Care as usual (n=24) Total
  3 6 (24) 8 (33) 14 (29)
Histology
  Endometrioid adenocarcinoma 21 (84) 19 (79) 40 (82)
  Serous carcinoma 1 (4) 3 (13) 4 (8)
  Mixed carcinoma 1 (4) 0 (0) 1 (2)
  Serous surface papillary carcinoma 0 (0) 1 (4) 1 (2)
  Carcinosarcoma 2 (8) 0 (0) 2 (4)
  Adenosquamous carcinoma 0 (0) 1 (4) 1 (2)
Histological type
  Type I 21 (84) 19 (79) 40 (82)
  Type II 4 (16) 5 (21) 9 (18)
Charlson Comorbidity Index
  2 18 (75) 21 (84) 39 (80)
  3 6 (25) 4 (16) 10 (20)
WHO performance status
  0 20 (83) 20 (80) 40 (82)
  1 3 (13) 5 (20) 8 (16)
  2 1 (4) 0 (0) 1 (2)
Selected comorbidities
  Diabetes 3 (12) 4 (17) 7 (14)
  Hypertension 6 (24) 7 (29) 13 (27)
  Dyslipidaemia 3 (12) 3 (13) 6 (12)
  Asthma 1 (4) 2 (8) 3 (6)
  Osteoporosis 2 (8) 4 (17) 6 (12)
  Weight, mean kg (SD) 69.8 (14.8) 71.9 (15.2) 70.9 (14.9)
  BMI, mean kg/m2 (SD) 27.3 (6.5) 28.8 (6.1) 28.0 (6.3)
  BMI, median kg/m2 (IQR) 26.2 (24.3) 26.9 (8.6) 26.8 (6l.4)
  % Fat, mean (SD) 35.3 (7.7) 36.9 (6.3) 36.1 (7.0)
Percentages might not add to 100 due to rounding.
Data are presented as n (%) unless otherwise specified.
Body composition data for usual care n=23.
BMI, body mass index; DEUS, Diet and Exercise in Uterine Cancer Survivors; IMD, index of multiple deprivation.
Table 2 Continued 
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trials.25 Limitations of the study include the small sample 
size, recruitment from only two London-based sites, and 
generalisability of the recruited sample, as sociodemo-
graphic data from decliners were missing. The relatively 
low median BMI of participants compared with epidemi-
ological studies26 indicates healthy volunteer effect biases. 
The wide socioeconomic and demographic differences 
of the population pools of the two hospitals27 and the 
similar recruitment rates at both sites were reassuring and 
suggest these factors should not impact recruitment and 
retention.
The focus of the study on healthy lifestyle changes 
rather than weight loss was postulated to increase uptake 
and acceptability of the programme.7 The overall recruit-
ment estimate was similar or somewhat higher than that 
in other lifestyle intervention trials, although differences 
in recruitment strategies, eligibility criteria, cancer site, 
programme length and intensity do not allow for direct 
comparisons. The group-based, 6-month Survivors of 
Uterine Cancer Empowered by Exercise and Healthy 
Diet (SUCCEED) intervention had a 19% recruitment 
rate using mail-out.12 A 12-week group-based physical 
activity intervention recruited 20% of the eligible ECS 
through fliers and telephone recruitment.28 Similar to 
DEUS, a more intensive lifestyle intervention in UK breast 
cancer survivors had a mail-out rate of 17%.29 While 
removing the transport and time barriers would theoreti-
cally improve recruitment rates, USA home-based lifestyle 
interventions recruiting cancer survivors from registries 
Table 3 Percentage programme satisfaction (n=18)









Organisation of the 
sessions
– – 100
Length of the programme – 11 89
Dates of the programme 6 17 78
Length of the sessions – – 100
Training location – – 100
Group format – – 100
Peer-education format – 6 94
Group discussion – – 100
Cultural sensitivity of the 
facilitator
– – 100
Facilitator’s knowledge of 
materials
– 6 94
Facilitator’s preparedness – – 100
Time used effectively by 
facilitator
– – 100
Attractiveness of the 
booklet
6 17 78
Overall design of the 
booklet
– 17 84
Wording of the booklet – 22 77
Volume of the booklet 17 22 61
Durability of the booklet – 17 83





When trying to make diet changes, how helpful did you find monitoring 
yourself using diaries?
– – 100
When trying to make physical activity changes, how helpful did you find 
monitoring yourself using diaries?
6% 6 88
When trying to make diet changes, how helpful did you find putting SMART 
goals? 
– 11 88
When trying to make physical activity changes, how helpful did you find 
putting SMART goals?
– 11 89
When trying to make diet changes, how helpful did you find rewarding 
yourself?
28% 33 39
When trying to make physical activity changes, how helpful did you find 
rewarding yourself?
28% 39 34
When trying to make diet changes, how helpful did you find the peer-
education nature of the sessions?
– 6 95
When trying to make physical activity changes, how helpful did you find the 
peer-education nature of the sessions?
– 17 83
SMART, specific, measurable, achievable, relevant, and time specific
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have shown much smaller recruitment rates (5.7%) with 
women, younger, white survivors, and those closer to their 
cancer diagnosis more likely to enrol.30
The observed adherence was lower compared with the 
weight loss SUCCEED intervention (84.1%) comprising 
16 group sessions12 but similar to that of a group-based 
12-week physical activity intervention.28 While this 
might indicate that survivors are more committed in 
weight loss programmes compared with healthy life-
style programmes, the main reported reasons regarding 
non-attendance in the current study were around practi-
calities and life commitments rather than disengagement 
with the programme. Sending a standardised email to 
non-attendees about topics covered in the missed session 
and preparation for the next session helped maintain 
their engagement.
Having a specific research room and two committed 
researchers in clinic facilitated recruitment. Screening 
participants using electronic forms and implementing 
further prerandomisation eligibility checks from medical 
notes could minimise randomisation of ineligible partic-
ipants. The recruitment rate, while similar between the 
two sites, was lower in the clinician-endorsed mail-out, 
indicating the higher effectiveness of the first approach 
that needs to be balanced with its higher resource 
requirements in larger trials. Practical reasons rendered 
intervention adherence acceptable but not optimal. The 
difficulty of trying to arrange a weekly group meeting 
with approximately eight people was evident, although a 
range of potential times was offered to participants and 
involved working around the logistics to find the most 
convenient date. Given the wide variability of partic-
ipants’ availability, simultaneous offers of a group on a 
weekday early evening or Saturday morning facilitated 
engagement in groups 2 and 3. In future studies, larger 
groups will be possible by unblinding investigators after 
enough participants are allocated to each trial arm to run 
two groups.
Opting for the group-based and face-to-face design 
aimed to meet survivors’ preferences7 but was in contrast 
with some previous studies reporting proximity as a 
particular barrier in this population.24 The lack of drop-
outs after the second group session indicated the overall 
acceptability of the intervention and the favourable rating 
of most programme aspects provides confidence that only 
minor content adaptations are needed before testing the 
study in a large trial. As multiple facilitators will deliver 
the intervention in a pragmatic setting, future large-scale 
trials should also measure differences in intervention 
delivery between various facilitators. Inconvenience and 
transport were the main barriers to accrual in the current 
study. Increasing reach might be more feasible with 
blended designs of group meetings and remote inter-
vention delivery, especially as home-based interventions 
have typically experienced much lower recruitment rates 
compared with group-based interventions. In the current 
programme, even those who adhered mentioned conve-
nience reasons as discouraging participation but the peer 
support as encouraging. This might suggest delivering 
some sessions in person and others remotely, potentially 
through web or mobile technology. A pilot weight loss 
study with endometrial and breast cancer survivors deliv-
ered via a mobile application has shown promising results 
in a pre–post design.31 However, further research on 
mobile applications for weight management is needed, as 
most lack evidence-based behaviour change techniques, 
involvement of healthcare professionals, and scientific 
evaluation.32
In conclusion, this self-help lifestyle intervention trial 
was feasible in terms of recruitment, adherence and 
retention. Scaling the trial will require close monitoring 
of recruitment and attempts should be made to reduce 
the burden on participants. Further qualitative work 
could inform a blended in-person and remote design 
to enhance adherence while retaining the valued peer 
support. This should be considered before proceeding to 
a definitive trial. Overall, the lessons learnt from this pilot 
should inform the design of future studies in this area.
Full protocol availability
The full protocol of the study has been previously 
published15 and it can also be found in the online supple-
mentary appendix 4.
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